ARV supply will not be impacted by supplier issues, says Minister Motsoaledi

Chante Ho Hip

Chante Ho Hip

26 January 2026 | 7:10

Two antiretroviral suppliers have entered business rescue, raising concerns over availability. More than six million people rely on ARVs from the Department of Health.

ARV supply will not be impacted by supplier issues, says Minister Motsoaledi

HIV AIDS antiretroviral

The Department of Health has assured the public that there is no shortage of antiretroviral (ARV) medications, despite two suppliers entering business rescue.

Health Minister Dr Aaron Motsoaledi said the Department has activated contingency plans, including engaging with other contracted suppliers to increase production and cover potential shortfalls.

The Department has also maintained a three-month buffer supply of stock.

With over six million people relying on ARVs, the programme’s stability is crucial. 

“It would be extremely dangerous for the country to run out of ARVs because we are running the world’s biggest antiretroviral programme. And if you run out of ARVs, you stand the risk of developing resistance; many more people get sick or die, or more expensive drugs will be needed,” he said.

On the introduction of Lenacapavir, a new once-a-year administered drug, Motsoaledi explained that it is currently only for HIV-negative individuals and will not affect the existing ARV programme.

“The ARV programme will continue. We are not going to stop it, and it will not be affected.”  

Get the whole picture 💡

Take a look at the topic timeline for all related articles.

Trending News